Why the study?
Does oral hydralazine and sublingual isosorbide dinitrate improve myocardial hemodynamics compared to dopamine in patients with refractory congestive heart failure?
Does oral hydralazine and sublingual isosorbide dinitrate improve myocardial hemodynamics compared to dopamine in patients with refractory congestive heart failure?
In patients with refractory heart failure, vasodilator therapy with hydralazine and isosorbide dinitrate provides superior hemodynamic benefits compared to dopamine, which may paradoxically worsen hemodynamics and mitral regurgitation in some patients.
May support vasodilator preference in refractory HF; leaves open confirmation versus dopamine in randomized trials.
Nine patients with refractory congestive heart failure underwent hemodynamic study first with dopamine and then with oral hydralazine and sublingual isosorbide dinitrate. Although hemodynamic improvement was achieved with both forms of therapy, the beneficial effects of hydralazine alone or with isosorbide were superior to those of dopamine, as manifested by a greater reduction of wedge pressure and greater increase in stroke index. Six patients who demonstrated an increased wedge pressure during dopamine infusion were observed to manifest a louder apical systolic murmur and/or V wave in the wedge pressure tracing suggestive of enhanced mitral regurgitation. The rise in wedge pressure on dopamine could also be a consequence of increased myocardial ischemia and resultant decrease in ventricular compliance. It is possible that a subgroup of patients with heart failure are made worse by dopamine, and in these cases vasodilator therapy may be more beneficial.
No takes yet. Share an insight, caveat, or question.
Biddle et al. (1981) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: